GlobeNewswire by notified

Festi hf.: Buy-back programme week 9

6.3.2023 09:35:00 CET | GlobeNewswire by notified

Share

In week 9 2023, Festi purchased in total 321,500 own shares for total amount of 58,047,000 ISK as follows:


WeekDateTimePurchased sharesPricePurchase priceTotal shares boughtTotal puchase price
927.2.202314:55:3250.0001839.150.0001.981.020352.699.002
928.2.202310:06:2230.0001825.460.0002.011.020358.159.002
928.2.202315:27:5450.000181,59.075.0002.061.020367.234.002
91.3.202311:35:06341806.1202.061.054367.240.122
91.3.202312:25:4040018072.0002.061.454367.312.122
91.3.202313:07:29121802.1602.061.466367.314.282
91.3.202314:19:2711018019.8002.061.576367.334.082
91.3.202314:26:5229.4441805.299.9202.091.020372.634.002
91.3.202315:24:081.500178267.0002.092.520372.901.002
92.3.202313:50:5730.000176,55.295.0002.122.520378.196.002
93.3.202311:20:453.000180540.0002.125.520378.736.002
93.3.202311:21:3427.0001804.860.0002.152.520383.596.002
93.3.202313:50:34100.00018018.000.0002.252.520401.596.002
321.50058.047.000


The execution the buy-back programme is in accordance with Chapter VIII of the Company Act No 2/1995 and annex II to the Regulation on insider information and market abuse No 630/2005.

Before the purchase Festi held 5,000,000 own shares or 1.60% of issued shares. Festi has now bought in total 2,252,520 own shares for 401,596,002 ISK and holds today 7,252,520 own shares or 2.32% of issued shares.This announcement of purchase of own shares is in accordance with the buy-back programme announced 6 January 2023 to Nasdaq OMX Iceland. The programme envisages the buy-back of a total of 3,000,000 own shares or 0.96% of the issued shares, with the cap of 650 million ISK purchase price.

For further information contact Magnús Kr. Ingason, CFO of Festi hf. (mki@festi.is).


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Fortuna files Form 40-F, Annual Report30.3.2023 23:15:00 CEST | Press release

VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that the Company has filed today its fiscal 2022 annual report on Form 40-F with the U.S. Securities and Exchange Commission (“SEC”). The Form 40-F, which includes the Company’s fiscal 2022 annual audited financial statements, management’s discussion and analysis, and annual information form, is available on the Company’s website and on the SEC´s website. Printed copies of the annual financial statements are available free of charge to Fortuna shareholders upon written request. About Fortuna Silver Mines Inc. Fortuna Silver Mines Inc. is a Canadian precious metals mining company with four operating mines in Argentina, Burkina Faso, Mexico and Peru, and a fifth mine under construction in Côte d'Ivoire. Sustainability is integral to all our operations and relationships. We produce gold and silver and generate shared value over the long-term for our stakeholders through

Samlede antal stemmerettigheder og aktiekapital i Pharma Equity Group A/S ("Selskabet")30.3.2023 23:13:48 CEST | pressemeddelelse

Pharma Equity Group A/S Selskabsmeddelelse Årets meddelelse nr.: 24 Dato: 30. marts 2023 Samlede antal stemmerettigheder og aktiekapital i Pharma Equity Group A/S ("Selskabet") I henhold til Lov om kapitalmarkeder (lovbekendtgørelse nr. 41 af 13. januar 2023) § 32 offentliggør Selskabet hermed det samlede antal stemmerettigheder og den samlede aktiekapital i Selskabet. Efter kapitalforhøjelse registreret den 24. marts 2023 vedrørende udstedelse af vederlagsaktier til aktionærerne i Reponex Pharmaceuticals A/S og nye aktier med fortegningsret for Selskabets eksisterende aktionærer i en fortegningsretsemission, hvor Selskabet i alt udstedte 978.584.263 stk. nye aktier à nominelt DKK 1,00 pr. aktie, udgør Selskabets samlede nominelle aktiekapital DKK 1.022.963.883 svarende til 1.022.963.883 antal aktier og 1.022.963.883 stemmer pr. 31. marts 2023 Yderligere information Alle henvendelser vedrørende ovenstående bedes venligst rettet til direktør Peter Ole Jensen på e-mailadressen: peter.ole

Multitude Group Annual Report for 2022 published30.3.2023 22:45:00 CEST | Press release

Multitude Group Annual Report for 2022 published Helsinki, 30 March 2023 – Multitude SE (ISIN: FI4000106299, WKN: A1W9NS) (“Multitude” or the “Group”) is pleased to announce that the Group's Annual Report, Corporate Governance Statement and Remuneration Report for the year ended 31 December 2022 have been published today on the company’s website. The Annual Report consists of annual review and financial review, including Board of Directors‘ report, consolidated financial statements and parent company’s financial statements. The annual review includes the ESG Report 2022 which comprises the non-financial statement. It outlines the Group’s ESG Goals and KPIs focused on people, processes, and the environment, with commencement of reporting on the Group’s carbon emissions. The ESG report 2022 further highlights the Group’s commitment to customer well-being through responsible lending practices and the introduction of a Responsible Lending Index and a commitment to progress on employee well

Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion30.3.2023 22:45:00 CEST | Press release

Company announcement – No. 11 / 2023 Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT; ANY PUBLIC OFFERING OF SUCH SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM THE ISSUER, WHICH WOULD CONTAIN DETAILED INFORMATION ABOUT THE COMPANY AND MANAGEMENT, AS WELL AS FINANCIAL STATEMENTS. As announced on 30 March 2023, Zealand Pharma commenced

Multitude SE: Notice to Convene Multitude SE's Annual General Meeting of Shareholders30.3.2023 22:45:00 CEST | Press release

NOTICE TO CONVENE MULTITUDE SE’S ANNUAL GENERAL MEETING OF SHAREHOLDERS Notice is given to the shareholders of Multitude SE (Company) that the Annual General Meeting of the Company is to be held on 27 April 2023 at 10:00 a.m. (EEST / Finnish time) at the offices of Castrén & Snellman Attorneys Ltd, Eteläesplanadi 14, Helsinki, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will start at 9:30 a.m. (EEST / Finnish time). Shareholders may also exercise their voting rights by voting in advance. Instructions concerning advance voting are provided in Section 3.4 of this notice. It will not be possible to participate in the meeting or follow the meeting via an online stream or otherwise in real time by the use of telecommunication connections or technical means. The meeting will be held in the English language. 1 MATTERS ON THE AGENDA OF THE GENERAL MEETING OF SHAREHOLDERS At the General Meeting of Shareholders, the following matte